External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Metabolism ADA 2025
Roche and Genentech at

ADA 2025

June 20 - June 23
Chicago, USA / Virtual (Hybrid)
ada.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:30 PM
Duration 60mins Chicago, USA
Effect of CT-388, a Signal-Biased Dual GLP-1/GIP Receptor Agonist, on Liver-Related MRI Parameters in Patients With Obesity
Alexandra Steinberg, Federico A Argüelles-Tello, Jiawen Zhu, Jingtao Wu, Helena B Thomaides Brears, Caitlin R Langford, Michael A Elliott, Luis Acosta, Leyla Leticia Sanchez-Sanchez; Manu V Chakravarthy
Metabolism | Obesity

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:30 PM
Duration 60mins Chicago, USA
Interim Analysis of an Observational Study Investigating User Satisfaction and Glycemic Outcome in PwT1D Using the Accu-Chek Solo Micropump
Sandra Moceri Dain, Alejandro; Dagenbach, Nicole; Vogt, Gerhard; Etter, Tobias
Metabolism | Diabetes Mellitus

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Chicago, USA
Glycemic Control, Weight Reduction, and Safety with CT-388, A Signal-Biased Dual GLP-1/GIP Receptor Agonist: Results From a 12-Week Cohort in Adults With Obesity and Type 2 Diabetes
Alexandra Steinberg, Federico A Argüelles-Tello, Leyla L Sanchez-Sanchez, Walter Garcia Ortiz, Michael A Elliott, Jingtao Wu, Jiawen Zhu, Esther Shearer-Kang, Luis Acosta, Jeffrey R Willis, Manu V Chakravarthy
Metabolism | Diabetes Mellitus Type II

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Chicago, USA
Accompanying slide deck for ADA Poster titled: Glycemic Control, Weight Reduction, and Safety with CT-388, A Signal-Biased Dual GLP-1/GIP Receptor Agonist: Results From a 12-Week Cohort in Adults With Obesity and Type 2 Diabetes
Alexandra Steinberg, Federico A Argüelles-Tello, Leyla L Sanchez-Sanchez, Walter Garcia Ortiz, Michael A Elliott, Jingtao Wu, Jiawen Zhu, Esther Shearer-Kang, Luis Acosta, Jeffrey R Willis, Manu V Chakravarthy
Metabolism | Diabetes Mellitus Type II

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.